An immunologic portrait of cancer - Wikidata - wikimedia - TriplyDB

An immunologic portrait of cancer

An immunologic portrait of cancer

http://www.wikidata.org/entity/Q27028000

about

Cancer classification using the Immunoscore: a worldwide task force Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy Therapeutic cancer vaccines: past, present, and future Reflections upon human cancer immune responsiveness to T cell-based therapy Towards the introduction of the 'Immunoscore' in the classification of malignant tumours Impact of carbon nanotubes and graphene on immune cells Melanoma NOS1 expression promotes dysfunctional IFN signaling Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.The stable traits of melanoma genetics: an alternate approach to target discovery Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity A genetic inference on cancer immune responsiveness IRF5 gene polymorphisms in melanoma Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.CD4⁺ follicular helper T cell infiltration predicts breast cancer survival IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Immune biomarkers: how well do they serve prognosis in human cancers?CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer Multicolor Immunofluorescent Imaging of Complex Cellular Mixtures on Micropallet Arrays Enables the Identification of Single Cells of Defined Phenotype.GBP-1 acts as a tumor suppressor in colorectal cancer cells.Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.Common pathways to tumor rejection.The immune score as a new possible approach for the classification of cancer.Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.Toward integrative cancer immunotherapy: targeting the tumor microenvironment.The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model.

P2860

Q21245495-26E7BFDC-8BFF-478D-9C95-F2527E7E6DDD Q26798404-1AA0D029-66D7-4663-ADB0-3E20DAD4E724 Q26863283-94749B09-C48C-4EE3-B3A0-B1C25B84B2D1 Q27004674-6219BB4C-241E-442D-8F79-EABCA831EFDF Q27026489-AE3947F8-135E-4A96-A022-264A48A8AF1E Q28388540-3BEF6916-3EAE-4936-88F3-FE94E5C967B9 Q30413226-19AE21AD-FC99-4FDA-ADFD-A33BFBB98AD1 Q30423599-E72A2669-40DE-4D26-AFDD-C82295331BD8 Q30542070-F5788B6B-AC41-498C-B329-51D224B72AE0 Q33750137-BD55D023-3D29-4F74-9ACB-E77BD5E71443 Q34248355-C93C2879-E349-4EEB-99C5-1AFAE7B42BCC Q34338284-38D8D071-2540-441A-A12E-6CF8D95BD041 Q34387506-D75FFF9D-DC29-4E99-8657-819293F2DAFD Q34799946-2D0602AF-1204-4107-8B21-A72B8F24BB5A Q35506764-ED61105E-6D11-4969-918E-9326E91248BC Q35541507-A27419EB-AF42-4C70-B627-493B49D02847 Q35908369-0378AD05-5741-48A4-93F5-74C9E6EEB2E8 Q36057497-5B84CD91-F7AF-4275-98ED-5B29D83A82AA Q36380375-33557E10-6BE6-4712-BBE3-438A6EAF3F8C Q36664277-20D529E7-CCB1-4EE0-909F-866089DF9A82 Q36960012-2050A824-407D-4AA8-ADF2-ABF80FBF1334 Q36966923-1CB280F1-CAA6-4086-8887-C7291E854CF7 Q37003368-C79CED75-CB0F-4323-8E36-4F7B1198BDD6 Q37191112-12291716-B36A-4722-A518-C8A651E6A3D0 Q37279217-4CAD2153-EB3A-43C6-A44A-A162A0916722 Q37637243-AC0F044A-0E4A-4F5A-9F50-BBD0E7D3AC50 Q37709496-5D82A5C4-B721-4B1A-8719-C57D495F1689 Q37713503-6F2B6B73-6EBE-4B39-AC54-F374CAFA5207 Q38101679-9556A6CF-1708-4F7B-AE90-263BBE529EFB Q38195656-327FBFDD-E17D-4DA3-AF0F-1ABAE3F761DD Q38262757-76B23F58-7390-4750-B104-324277772C18 Q38751056-83D315E2-5B53-4ADD-83E8-3B89B09F67CA Q38790286-55EEB843-BB0D-4D37-AE15-258A0FFFD37A Q39264514-21F65DF6-2015-427F-9478-7ADD075B9DF9 Q40963026-17E4C704-F64C-4DBF-B549-6E8A1D1AE0FD Q42263938-24E03563-C5BF-4607-B880-399E6A8EC3F9 Q42539190-25CA0697-49D4-4D60-AF6D-5B42CD170D15 Q42575965-9F5FDFB6-F0B2-4035-A8DC-C375E88CE65D Q43158322-9B09FDD4-FC48-4C43-B607-69228335781F Q46156982-6A7831A4-E351-4782-BB87-CBB9AFD81351

P2860

An immunologic portrait of cancer

http://www.wikidata.org/entity/Q27028000

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

An immunologic portrait of cancer

@ast

An immunologic portrait of cancer

@en

An immunologic portrait of cancer

@nl

type

label

An immunologic portrait of cancer

@ast

An immunologic portrait of cancer

@en

An immunologic portrait of cancer

@nl

prefLabel

An immunologic portrait of cancer

@ast

An immunologic portrait of cancer

@en

An immunologic portrait of cancer

@nl

P1433

Q27028000-3DA85925-0164-41FD-A019-6CDDDFBB6B62

P1476

Q27028000-0F0351CE-4F41-41C7-9F49-5FD3886F3EC0

P2093

Q27028000-1BA93758-1545-4945-9ECA-86A8126844B8

Q27028000-2C746EB0-5D1B-4B0B-BCEF-6C37536763D1

Q27028000-4FBD25BB-7DAF-4FB9-9C97-85398D86E9FD

Q27028000-68B5A9F4-606A-4521-A877-F16DEF52E81B

Q27028000-837C5A4D-4475-4CD1-A085-68959916A873

Q27028000-9ECBED55-D3CA-4E8C-A3D6-8088FC3F338A

Q27028000-A303DEF0-F8D2-4B3D-8204-48AF30CA6A7D

Q27028000-A7C24910-BFD0-40D5-BC26-217B067DDDDB

Q27028000-B4B24A0D-63BA-49B1-8E86-5C58B7AB1CAA

Q27028000-C5E4CA2B-B26D-410A-ABF9-3950F6FC5545

P275

Q27028000-A3250D68-222B-4093-A421-DEB04F15FD32

P2860

Q27028000-02C2904A-C857-407B-8A63-B1386288F7C8

Q27028000-039A0119-6FB8-402A-8A8D-40C37C3C9560

Q27028000-0783A4CE-8665-4EB6-9C38-B322CA23301B

Q27028000-07A4E333-5B18-4F2B-A2C6-B6CAD1008586

Q27028000-0E5FCA48-34E0-4A4D-A0AB-724B38F9F1C9

Q27028000-0E8D4C8F-9E87-4898-9978-EA6F660E3B09

Q27028000-1175930C-3699-4AF3-9C0E-13E7241BCAF5

Q27028000-15455955-558D-41BC-9E9D-7FCCD162E974

Q27028000-15D95B53-1F4B-4CC2-891D-770F7A6E67F0

Q27028000-16917E27-3979-4779-98DC-30C88773A0C5

P2888

Q27028000-D83B8A58-9B0A-4064-8136-E71C5E068A3D

P304

Q27028000-169E3E41-FE90-46C4-B2FD-E7D393656030

P31

Q27028000-18D521E9-16F8-4638-9802-F69513B0E77F

Q27028000-A26CD85C-8784-4E18-8115-B5A92FDAA574

P3181

Q27028000-93EE0517-38D3-4963-94FC-97E17662EABB

P356

Q27028000-A91409A3-4F11-4A03-8164-4AA63EEC22F7

P407

Q27028000-89A02D58-D6EA-4DD8-91CF-D5285DAABA6F

P433

Q27028000-2AB79FD0-E387-4CB6-A0A2-B26DA27BECE3

P478

Q27028000-10BEC579-13CE-447C-84B2-0A4C01D9D5AF

P5008

Q27028000-8B32951A-D717-483C-8455-0F889C8DB8C5

P577

Q27028000-F3190432-5755-47DA-A061-961C4EBB2A24

P5875

Q27028000-BBD59029-A325-4D24-A802-F26F1D72026B

P6179

Q27028000-25707A02-D706-454B-B9F4-9E07709FD0E4

P698

Q27028000-D682FF14-0E19-4628-934D-AFCAEE96FC31

P921

Q27028000-1D42C697-49CD-41B6-853B-827ED919B594

P932

Q27028000-09806479-C6D6-4159-87A1-DBBEFC698D57

P3181

P356

1479-5876-9-146

P1433

Journal of Translational Medicine

P1476

An immunologic portrait of cancer

@en

P2093

Ben D Ayotte

http://www.w3.org/2001/XMLSchema#string

Daniela Murtas

http://www.w3.org/2001/XMLSchema#string

David F Stroncek

http://www.w3.org/2001/XMLSchema#string

Davide Bedognetti

http://www.w3.org/2001/XMLSchema#string

Ena Wang

http://www.w3.org/2001/XMLSchema#string

Francesco M Marincola

http://www.w3.org/2001/XMLSchema#string

Lorenzo Uccellini

http://www.w3.org/2001/XMLSchema#string

Lotfi Chouchane

http://www.w3.org/2001/XMLSchema#string

Maria Ascierto

http://www.w3.org/2001/XMLSchema#string

Masoud H Manjili

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Gene expression profiling predicts clinical outcome of prostate cancer

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

The IRF family, revisited

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Melanoma-restricted genes

Structure of IRF-1 with bound DNA reveals determinants of interferon regulation

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Gene expression profiling predicts clinical outcome of breast cancer

Immunity, Inflammation, and Cancer

Molecular portraits of human breast tumours

P2888

1479-5876-9-146

P304

146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

872178

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1479-5876-9-146

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51603378

http://www.w3.org/2001/XMLSchema#string

P6179

1030262859

http://www.w3.org/2001/XMLSchema#string

P698

21875439

http://www.w3.org/2001/XMLSchema#string

P921

P932

3175185

http://www.w3.org/2001/XMLSchema#string